Literature DB >> 25142804

High levels of CD4⁺ CTLA-4⁺ Treg cells and CCR5 density in HIV-1-infected patients with visceral leishmaniasis.

A Vallejo1, M Abad-Fernández, S Moreno, A Moreno, M J Pérez-Elías, F Dronda, J L Casado.   

Abstract

Visceral leishmaniasis (VL) in HIV-1-infected patients has been associated with poor immunological recovery and frequent disease relapses. The aim of this study was to analyse the role of T cell populations, Treg cells and CCR5 density in patients with VL compared to HIV-1-infected patients without leishmaniasis. A cross-sectional study of nine Leishmania-HIV-1-coinfected (LH) patients with VL receiving suppressive cART for at least 1 year were compared to 16 HIV-1-infected patients with non-immunological response (NIR, CD4 count below 250 cells/mm(3)) and 26 HIV-1-infected patients with immunological response (IR, CD4 count above 500 cells/mm(3)) without leishmaniasis. LH patients had a deep depletion of naïve T cells (p = 0.002), despite similar levels of effector T cells compared to NIR patients. CD4 Treg cells were similar compared to NIR patients, but higher compared to IR patients (p < 0.001). Interestingly, CD4 Treg CTLA-4(+) cells were higher in LH patients compared to either NIR or IR patients (p = 0.022 and p < 0.001, respectively), and the CD4 Treg/TEM ratio was similar to NIR patients, but higher compared to IR patients (p = 0.017). CCR5(+) T cell levels were higher compared to IR patients (p < 0.001), while CCR5 density on T cells were higher compared to both NIR and IR patients (p < 0.005 in both cases). Higher levels of CD4(+) CTLA-4(+) Treg cells and CCR5 density on CD8(+) T cells are strongly associated with VL in HIV-1-infected patients. Also, these patients have a poor immunological profile that might explain the persistence and relapse of the pathogen.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25142804     DOI: 10.1007/s10096-014-2229-1

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  39 in total

1.  Infection of human mononuclear phagocytes and macrophage-like THP1 cells with Leishmania donovani results in modulation of expression of a subset of chemokines and a chemokine receptor.

Authors:  B Dasgupta; K Roychoudhury; S Ganguly; M A Akbar; P Das; S Roy
Journal:  Scand J Immunol       Date:  2003-04       Impact factor: 3.487

Review 2.  Regulatory T cells in the control of host-microorganism interactions (*).

Authors:  Yasmine Belkaid; Kristin Tarbell
Journal:  Annu Rev Immunol       Date:  2009       Impact factor: 28.527

3.  HIV-activated human plasmacytoid DCs induce Tregs through an indoleamine 2,3-dioxygenase-dependent mechanism.

Authors:  Olivier Manches; David Munn; Anahita Fallahi; Jeffrey Lifson; Laurence Chaperot; Joel Plumas; Nina Bhardwaj
Journal:  J Clin Invest       Date:  2008-10       Impact factor: 14.808

4.  Visceral leishmaniasis in human immunodeficiency virus (HIV)-infected and non-HIV-infected patients. A comparative study.

Authors:  V Pintado; P Martín-Rabadán; M L Rivera; S Moreno; E Bouza
Journal:  Medicine (Baltimore)       Date:  2001-01       Impact factor: 1.889

5.  Defects in the generation of IFN-gamma are overcome to control infection with Leishmania donovani in CC chemokine receptor (CCR) 5-, macrophage inflammatory protein-1 alpha-, or CCR2-deficient mice.

Authors:  N Sato; W A Kuziel; P C Melby; R L Reddick; V Kostecki; W Zhao; N Maeda; S K Ahuja; S S Ahuja
Journal:  J Immunol       Date:  1999-11-15       Impact factor: 5.422

6.  Mixed inflammatory/regulatory cytokine profile marked by simultaneous raise of interferon-gamma and interleukin-10 and low frequency of tumour necrosis factor-alpha(+) monocytes are hallmarks of active human visceral Leishmaniasis due to Leishmania chagasi infection.

Authors:  V Peruhype-Magalhães; O A Martins-Filho; A Prata; L De A Silva; A Rabello; A Teixeira-Carvalho; R M Figueiredo; S F Guimarães-Carvalho; T C A Ferrari; J Van Weyenbergh; R Correa-Oliveira
Journal:  Clin Exp Immunol       Date:  2006-10       Impact factor: 4.330

7.  Aberrant induction of regulatory activity of CD4+CD25+ T cells by dendritic cells in HIV-infected persons with amebic liver abscess.

Authors:  Szu-Min Hsieh; Mao-Yuan Chen; Sung-Ching Pan; Chien-Ching Hung; Shan-Chwen Chang
Journal:  J Acquir Immune Defic Syndr       Date:  2007-01-01       Impact factor: 3.731

Review 8.  The relationship between leishmaniasis and AIDS: the second 10 years.

Authors:  Jorge Alvar; Pilar Aparicio; Abraham Aseffa; Margriet Den Boer; Carmen Cañavate; Jean-Pierre Dedet; Luigi Gradoni; Rachel Ter Horst; Rogelio López-Vélez; Javier Moreno
Journal:  Clin Microbiol Rev       Date:  2008-04       Impact factor: 26.132

9.  Leishmania induces survival, proliferation and elevated cellular dNTP levels in human monocytes promoting acceleration of HIV co-infection.

Authors:  David J Mock; Joseph A Hollenbaugh; Waaqo Daddacha; Michael G Overstreet; Chris A Lazarski; Deborah J Fowell; Baek Kim
Journal:  PLoS Pathog       Date:  2012-04-05       Impact factor: 6.823

10.  High CCR5 density on central memory CD4+ T cells in acute HIV-1 infection is mostly associated with rapid disease progression.

Authors:  Xue Yang; Yan-mei Jiao; Rui Wang; Yun-xia Ji; Hong-wei Zhang; Yong-hong Zhang; De-xi Chen; Tong Zhang; Hao Wu
Journal:  PLoS One       Date:  2012-11-21       Impact factor: 3.240

View more
  5 in total

1.  Relationship between CCR5+FoxP3+ Treg cells and forced expiratory volume in 1 s, peak expiratory flow in patients with severe asthma.

Authors:  Łukasz Kraszula; Makandjou-Ola Eusebio; Piotr Kuna; Mirosława Pietruczuk
Journal:  Postepy Dermatol Alergol       Date:  2021-05-22       Impact factor: 1.837

Review 2.  Modulation of Innate Immune Mechanisms to Enhance Leishmania Vaccine-Induced Immunity: Role of Coinhibitory Molecules.

Authors:  Sreenivas Gannavaram; Parna Bhattacharya; Nevien Ismail; Amit Kaul; Rakesh Singh; Hira L Nakhasi
Journal:  Front Immunol       Date:  2016-05-13       Impact factor: 7.561

Review 3.  Visceral leishmaniasis and HIV coinfection: current perspectives.

Authors:  José Angelo Lauletta Lindoso; Carlos Henrique Valente Moreira; Mirella Alves Cunha; Igor Thiago Queiroz
Journal:  HIV AIDS (Auckl)       Date:  2018-10-15

4.  Case Report: Leishmania and HIV Co-Diagnosis: How to Understand Medical History?

Authors:  Arthur Dujardin; Arnaud de La Blanchardière; Julia Dina; Karl Stefic; Christophe Ravel; Julie Bonhomme; Renaud Verdon; Anna Lucie Fournier
Journal:  Front Immunol       Date:  2021-04-21       Impact factor: 7.561

Review 5.  The Contribution of Immune Evasive Mechanisms to Parasite Persistence in Visceral Leishmaniasis.

Authors:  Elisangela Oliveira de Freitas; Fabiana Maria de Souza Leoratti; Célio Geraldo Freire-de-Lima; Alexandre Morrot; Daniel Ferreira Feijó
Journal:  Front Immunol       Date:  2016-04-22       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.